drugset / Trial / NCT00335647
Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as fluphenazine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I/II trial is studying the side effects and best dose of fluphenazine and to see how well it works in treating patients with refractory advanced multiple myeloma.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluphenazine | Small molecule | — | Intravenous |